Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Cetirizine HCl Gummy vs Tablet
NCT04071821Phase 1Not yet recruiting
- Sponsor
- Seattle Gummy Company
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Ceteric in allergy (5 arms), sponsored by Seattle Gummy Company. Primary endpoints: Maximum Plasma Cetirizine Concentration at 2 months and Area Under the Plasma Drug Concentration versus Time Curve at 2 months. Planned start May 2025; status: not yet recruiting.
02
Drugs
Ceteric
03
Conditions
allergy
Beyond the preview
Go deeper on NCT04071821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04071821.